Quantcast
Channel: XconomySynthetic Biology – Xconomy
Browsing all 79 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Verdezyne Identifies First Product

Bruce V. Bigelow When I profiled Verdezyne in November, the Carlsbad, CA-based startup didn’t want to disclose the first feedstock chemical it is aiming to displace by using genetically engineered...

View Article



Image may be NSFW.
Clik here to view.

DNA Synthesis for Beginners: Ginkgo BioWorks Sells the Scissors and Glue

Erin Kutz The founders of Boston-based Ginkgo BioWorks think that assembling synthetic biological systems shouldn’t just be for experienced researchers. So they put together a kit that consists of the...

View Article

Image may be NSFW.
Clik here to view.

David Berry of Flagship Ventures on Funding Advice, Investment Themes, Trends...

Gregory T. Huang A rising star of the Boston-area venture capital scene is in Seattle today. He’s David Berry, a partner with Flagship Ventures, and he’s speaking on a panel tonight that will tackle a...

View Article

Image may be NSFW.
Clik here to view.

Life Tech Buys Majority of Geneart

Luke Timmerman Life Technologies,  the Carlsbad, CA-based company that makes instruments and lab supplies for biologists, said today it has acquired a 74 percent ownership stake in Germany-based...

View Article

Image may be NSFW.
Clik here to view.

Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into...

Bruce V. Bigelow The big news came with a guilty plea by Sequenom’s former R&D chief, but it’s just the beginning. In pleading guilty, Elizabeth Dragon agreed to cooperate with a continuing...

View Article


Image may be NSFW.
Clik here to view.

LS9, Creator of Synthetic Microbes to Make Biofuel, Edges Toward Moment of Truth

Luke Timmerman Every hot startup has to put up or shut up at some point. This is when it’s time to stop talking about the gee-whiz founding idea and scientific progress. It’s the point when a company...

View Article

Image may be NSFW.
Clik here to view.

Amyris Raises $85 Million in IPO

Wade Roush Emeryville, CA-based Amyris Biotechnologies is unusual in several respects. One of the synthetic biology company’s first big projects, back in 2005, was a non-profit venture with the Bill...

View Article

Image may be NSFW.
Clik here to view.

Life Technologies’ Recent Deals Reflect $100M Initiative in Synthetic Biology

Bruce V. Bigelow Back on May 28th, Carlsbad, CA-based Life Technologies (NASDAQ: LIFE) said it had agreed to pay approximately $47 million in cash to acquire a 74 percent stake in Geneart, a German...

View Article


Image may be NSFW.
Clik here to view.

Venter Institute, Synthetic Genomics Form Vaccine Company, Partner With Novartis

Bruce V. Bigelow San Diego’s Synthetic Genomics, co-founded by human genome pioneer J. Craig Venter, and the nonprofit J. Craig Venter Institute, are forming a new company called Synthetic Genomics...

View Article


Image may be NSFW.
Clik here to view.

Craig Venter to NASA: Think About Engineering Your Astronauts

Deborah Gage What is the right genetic profile for an astronaut—someone who’s going to spend months living on the moon, or years traveling to an asteroid or Mars? Craig Venter has an answer. The...

View Article

Image may be NSFW.
Clik here to view.

Novophage Nets $5.7M from Flybridge, Others

Gregory T. Huang Boston-based Novophage has raised $5.7 million in a Series A financing round led by Flybridge Capital Partners. Founder Collective, Boston University, and strategic investors Chevron...

View Article

Image may be NSFW.
Clik here to view.

Bacteria to Do Our Bidding

Matthew O'Donnell [Editor's note: We asked a group of Xconomists to answer the following question: "If you could patent one thing, what would it be?"] Broad claims covering delivery of therapeutics...

View Article

Image may be NSFW.
Clik here to view.

Computing and-Chinese

Nathan Myhrvold My initial response to this question was, “Chinese!” I was only half joking. English is the most popular second language in the world and in our increasingly connected world, the...

View Article


Image may be NSFW.
Clik here to view.

Stealthy Gen9 Rolls Out BioFab for Large-Scale Gene Manufacturing

Arlene Weintraub For the past three years, Cambridge, MA-based Gen9 has been quietly building something that its founders believe has been sorely lacking in biotech: an affordable and efficient way to...

View Article

Image may be NSFW.
Clik here to view.

Ziopharm Awaits Cancer Drug Data as Wall Street Withholds Judgment

Arlene Weintraub Jonathan Lewis, the CEO of New York-based Ziopharm (NASDAQ: ZIOP), was stunned earlier this year when he ran across a commercial on YouTube produced by his company’s biggest investor,...

View Article


Image may be NSFW.
Clik here to view.

Synthetic Genomics Gets Rights to Key Genome-Building Technology

Bruce V. Bigelow Synthetic Genomics, the San Diego startup developing biofuels, industrial chemicals, sustainable animal feed, and other genetically engineered products, says it has acquired worldwide...

View Article

Image may be NSFW.
Clik here to view.

In San Diego Talk, Venter Says Biofuels ‘Dead’ Without Carbon Policy

Bruce V. Bigelow Blunt to the bone, human genome pioneer J. Craig Venter flatly declared in San Diego this week that algae-based biofuels “are just dead” unless the federal government sets an...

View Article


Image may be NSFW.
Clik here to view.

Ziopharm Goes Lean to Stretch Funds for New Synthetic Biology Focus

Bernadette Tansey New York-based Ziopharm Oncology (NASDAQ: ZIOP), which once seemed on the runway toward its first product approval for a relatively conventional cancer drug, is now buying itself...

View Article

Image may be NSFW.
Clik here to view.

Gen9, Synthetic Biology Startup, Snags $21M from Agilent

Luke Timmerman [Updated: 1:15 pm ET] Scientists have been able to order up custom-synthesized genes on demand for quite a few years now. But if synthetic biology is going to move beyond small lab...

View Article

Image may be NSFW.
Clik here to view.

San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More

Bruce V. Bigelow [Clarification 5/17/13, 2:05 pm. See below.] Right on the same line with the original lede so you don’t waste space on a carriage return…Antibody drugs seemed to be the topic of the...

View Article
Browsing all 79 articles
Browse latest View live




Latest Images